NDC 51662-1555
HYALURONIDASE
Hyaluronidase
HYALURONIDASE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Hyaluronidase (human Recombinant).
| Product ID | 51662-1555_c3f1db01-58c0-2226-e053-2a95a90a8b33 |
| NDC | 51662-1555 |
| Product Type | Human Prescription Drug |
| Proprietary Name | HYALURONIDASE |
| Generic Name | Hyaluronidase |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2021-06-04 |
| Marketing Category | BLA / |
| Application Number | BLA021859 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | HYALURONIDASE (HUMAN RECOMBINANT) |
| Active Ingredient Strength | 150 [USP'U]/mL |
| Pharm Classes | Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |